Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Abrocitinib may effectively treat stubborn alopecia universalis.

The new drug delivery system effectively targets lung cancer cells.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

The compound 4c showed strong potential as an anticancer agent.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.